TRACY BANGHART: Open Payments
NPI 1689332041 · LA PORTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,256 in 66 payments from 7 companies in 2025. Trend: 2023 $1,061 · 2024 $1,884 · 2025 $1,256
Food & beverage: $1,256
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $587 |
| Janssen Biotech, Inc. | 17 | $338 |
| VIVUS LLC | 5 | $87 |
| Phathom Pharmaceuticals, Inc. | 5 | $83 |
| Ipsen Biopharmaceuticals, Inc | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| GENZYME CORPORATION | 1 | $28 |
Products named: TREMFYA, LINZESS, CREON, VIBERZI, PANCREAZE, RINVOQ, VOQUEZNA, IQIRVO.
Industry payments across IN — which companies pay providers there.
